Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Lilly's lupus treatment succeeds in mid-stage trial
Reuters
Thu, 06/14/18 - 09:45 am
Tags:
Eli Lilly, lupus, olumiant, baricitinib, clinical trials
Eli Lilly and AstraZeneca Drop PhIII Alzheimer's Candidate – BACE Class May Be Done
CP Wire
Tue, 06/12/18 - 09:16 am
Tags:
Eli Lilly, AstraZeneca, lanabecestat, Alzheimer's disease, BACE inhibitors
Tue, 06/12/18 - 09:02 am
Tags:
Eli Lilly, AstraZeneca, lanabecestat, Alzheimer's disease
Lilly's experimental colitis drug posts positive Phase 2 data
Biopharma Dive
Wed, 06/6/18 - 03:04 pm
Tags:
Eli Lilly, mirikizumab, ulcerative colitis, monoclonal antibodies
Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning
Xconomy
Fri, 06/1/18 - 10:36 pm
Tags:
Eli Lilly, Incyte, FDA, rheumatoid arthritis, olumiant, baricitinib
Novo Nordisk's oral diabetes drug beats Jardiance in study
Yahoo/Reuters
Tue, 05/29/18 - 09:02 pm
Tags:
diabetes, Novo Nordisk, semaglutide, Jardiance, Eli Lilly
Lilly's cancer business loses its chief just as it's leaning on oncology for growth
Fierce Pharma
Fri, 05/25/18 - 09:28 am
Tags:
Eli Lilly, oncology
Alzheimer’s Disease: Companies Weigh Revised FDA Draft Guidance
RAPS.org
Tue, 05/22/18 - 11:06 am
Tags:
Alzheimer's disease, FDA, Roche, AstraZeneca, Bioclinica, Eli Lilly, Denali Therapeutics
Lilly's CGRP drug succeeds in 'worst kind of migraine'
Biopharma Dive
Tue, 05/15/18 - 09:09 pm
Tags:
Eli Lilly, cluster headaches, migraines, galcanezumab
Eli Lilly Bolsters Cancer Drug Pipeline with $110M Deal for AurKa
Xconomy
Mon, 05/14/18 - 11:01 am
Tags:
Eli Lilly, AurKa Pharma, M&A
Eli Lilly Takes $7M Gamble On Global Health Working... In Indiana
Forbes
Mon, 05/14/18 - 09:22 am
Tags:
Eli Lilly, emerging markets
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 05/12/18 - 01:10 pm
Tags:
ARMO BioSciences, Eli Lilly, M&A, OPKO Health, Rayaldee, Arrowhead
Eight years after Eli Lilly dumped it, an upstart biotech has nabbed teplizumab and filed a $56M IPO to back a PhIII comeback
Endpoints
Thu, 05/10/18 - 11:02 pm
Tags:
teplizumab, Eli Lilly, Provention Bio, IPOs, diabetes
Lilly Acquires Immuno-Oncology Asset With $1.6 Billion Purchase of ARMO BioSciences
CP Wire
Thu, 05/10/18 - 10:34 am
Tags:
Eli Lilly, ARMO BioSciences, M&A, immuno-oncology
Thu, 05/10/18 - 10:17 am
Tags:
Eli Lilly, ARMO BioSciences, M&A
Eli Lilly Shares Seen Rising 18% as Profits Surge
Investopedia
Fri, 05/4/18 - 11:47 am
Tags:
Eli Lilly
Lilly, Pfizer, Sanofi lead in patent litigation, report says
Biopharma Dive
Thu, 05/3/18 - 12:11 pm
Tags:
Eli Lilly, Sanofi, Pfizer, patents, patent lawsuits, FDA
Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
Reuters
Tue, 04/24/18 - 10:47 pm
Tags:
Express Scripts, migraines, PBMs, Amgen, Eli Lilly
Lilly’s strong Q1 cushions the blow of FDA thumbs-down on high-dose baricitinib
Fierce Pharma
Tue, 04/24/18 - 10:44 pm
Tags:
Eli Lilly, earnings, baricitinib
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
Xconomy
Mon, 04/23/18 - 11:15 pm
Tags:
Eli Lilly, FDA, advisory panels, rheumatoid arthritis, baricitinib, Incyte

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.